The deal establishes a joint framework for managing and operating the unit, with operations, patient intake, and training programmes set to begin within three months of signing, according to the statement.
The partnership is part of efforts to expand access to advanced oncology services while strengthening Egypt’s capacity in medical training and research, particularly in radiotherapy and nuclear medicine.
The unit is equipped with a 6 MeV linear accelerator for cancer treatment using advanced radiotherapy techniques, as well as a PET-CT scanner for nuclear imaging and precise treatment planning to detect tumours and define therapy protocols.
Under the agreement, Alameda will oversee the facility's operations and management during periods when no formal training courses are held, ensuring continuity of care and optimal use of the equipment.
The cooperation also places strong emphasis on training and workforce development, targeting doctors, physicists, technicians, and engineers, alongside specialized programmes on nuclear safety and radiation protection to safeguard patients and medical staff.
In addition, the partnership includes engineering support to train technical personnel capable of maintaining and repairing complex medical equipment, ensuring long-term sustainability and efficiency of operations.
The unit will offer a comprehensive package of oncology services, including radiotherapy, chemotherapy, immunotherapy, and targeted therapy, as well as advanced diagnostic services such as PET-CT imaging. It is also set to serve as a regional hub for oncology training and research.
Under the arrangement, the Atomic Energy Authority will provide infrastructure, core equipment, and strategic oversight, while supporting research initiatives. Alameda will lead day-to-day operations, service development, and administrative management.
“With investments exceeding EGP 270 million, the unit is expected to serve more than 2,000 patients annually, contributing significantly to improving access to specialized cancer treatment in Egypt,” said Fahd Khater, chairman of Alameda Healthcare Group.
Atomic Energy Authority Chairman Amr El-Hag said the partnership represents a cornerstone in the authority’s strategy to enhance its national role in supporting the healthcare sector, particularly through building highly trained medical and engineering cadres and strengthening nuclear safety standards.
The agreement comes as Egypt accelerates efforts to expand specialized cancer care capacity amid rising demand for oncology services and increasing pressure on existing treatment centres, particularly in radiotherapy, where waiting lists have historically been a challenge.
Cancer remains one of the leading causes of death in Egypt, with breast, liver, and lung cancers among the most prevalent. Over the past decade, the government has prioritized early detection and treatment through nationwide screening campaigns, most notably the “100 Million Health” initiative, and by expanding access to advanced diagnostic and treatment technologies.
Radiotherapy is a key part of cancer treatment, needed in an estimated 50–60 percent of cases, but it is also highly resource-intensive, requiring specialized equipment, trained staff, and strict safety measures. This has led to gaps in access, especially outside major cities, prompting increased investment in infrastructure and workforce development.
Short link: